What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Leukemia
James W. Vardiman focuses on Pathology, Internal medicine, Leukemia, Myeloid and Immunology.
His Pathology study combines topics in areas such as Chemotherapy and Karyotype, Chromosome abnormality.
His work deals with themes such as Gastroenterology, Surgery, Oncology and Cytogenetics, which intersect with Internal medicine.
He has researched Leukemia in several fields, including Cancer, Myeloid leukemia, Survival analysis and Bone marrow.
The various areas that James W. Vardiman examines in his Myeloid study include Hematopathology and MEDLINE.
His Immunology study focuses on Myelodysplastic syndromes in particular.
His most cited work include:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
- World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. (3060 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Internal medicine, Leukemia, Immunology and Bone marrow.
The study incorporates disciplines such as Myeloid and Karyotype in addition to Pathology.
His Myeloid research incorporates themes from Myelofibrosis and Family medicine.
James W. Vardiman has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study.
His studies deal with areas such as Myeloid leukemia, Survival analysis, Chemotherapy and Cytogenetics as well as Leukemia.
His study looks at the relationship between Immunology and fields such as Cancer research, as well as how they intersect with chemical problems.
He most often published in these fields:
- Pathology (37.41%)
- Internal medicine (33.33%)
- Leukemia (33.70%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (33.33%)
- Cancer research (13.33%)
- Immunology (23.70%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cancer research, Immunology, Myeloid and Pathology.
His work deals with themes such as Gastroenterology, Surgery and Oncology, which intersect with Internal medicine.
His work on Myelodysplastic syndromes, Acute leukemia and T cell as part of general Immunology study is frequently linked to Chronic eosinophilic leukemia, therefore connecting diverse disciplines of science.
The Acute leukemia study combines topics in areas such as Mast cell leukemia and Intensive care medicine.
His studies in Myeloid integrate themes in fields like Myeloproliferative neoplasm and PDGFRB.
His Pathology research includes elements of Essential thrombocythemia and MEDLINE.
Between 2007 and 2021, his most popular works were:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
- Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. (845 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
James W. Vardiman mainly investigates Myeloproliferative neoplasm, Internal medicine, Immunology, Myelofibrosis and Myelodysplastic syndromes.
His study explores the link between Myeloproliferative neoplasm and topics such as Myeloid that cross with problems in PDGFRB, Dysplasia, NPM1 and Bone marrow.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Surgery and Oncology.
His study looks at the intersection of Surgery and topics like Leukemia with Cancer.
His Myelodysplastic syndromes study is related to the wider topic of Pathology.
His Acute leukemia study combines topics from a wide range of disciplines, such as Acute erythroid leukemia and Atypical chronic myeloid leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
